Yun-Wei Lin Selected Research

Topoisomerase II Inhibitors

1/2018	17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells.
12/2015	Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
3/2012	Inhibition of p38 MAPK-dependent excision repair cross-complementing 1 expression decreases the DNA repair capacity to sensitize lung cancer cells to etoposide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yun-Wei Lin Research Topics

Disease

38	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 11/2008
34	Lung Neoplasms (Lung Cancer) 04/2022 - 06/2003
30	Neoplasms (Cancer) 04/2022 - 06/2003
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2022 - 11/2008
7	Adenocarcinoma of Lung 04/2022 - 09/2011
4	Adenocarcinoma 01/2021 - 11/2008
3	Complementation Group C Xeroderma Pigmentosum 01/2021 - 01/2018
3	Breast Neoplasms (Breast Cancer) 01/2015 - 07/2012
3	Carcinoma (Carcinomatosis) 12/2013 - 05/2008
1	Squamous Cell Carcinoma of Head and Neck 01/2015
1	Type 2 Diabetes Mellitus (MODY) 02/2013
1	Chromosomal Instability (Chromosome Stability) 12/2009
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 11/2008

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 04/2022 - 05/2008
9	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 07/2008
9	Tyrosine Kinase InhibitorsIBA 05/2019 - 08/2009
8	Pharmaceutical PreparationsIBA 04/2022 - 07/2011
8	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 08/2008
8	ErbB Receptors (EGF Receptor)IBA 05/2019 - 05/2008
8	Thymidine PhosphorylaseIBA 01/2019 - 03/2011
7	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 08/2009
7	Gefitinib (Iressa)FDA Link 05/2015 - 05/2008
6	tanespimycin (17AAG)IBA 01/2021 - 03/2012
6	Rad51 RecombinaseIBA 09/2011 - 05/2008
5	Thymidylate SynthaseIBA 01/2020 - 07/2011
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 04/2010
5	Emodin (Archin)IBA 03/2011 - 09/2009
4	Pemetrexed (MTA)FDA Link 04/2022 - 12/2013
4	EnzymesIBA 01/2020 - 03/2011
4	CurcuminIBA 06/2016 - 07/2011
4	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2016 - 04/2010
4	DNA (Deoxyribonucleic Acid)IBA 03/2012 - 09/2009
3	Folic Acid AntagonistsIBA 04/2022 - 12/2013
3	salinomycinIBA 01/2019 - 12/2016
3	astaxanthine (astaxanthin)IBA 11/2018 - 04/2016
3	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 03/2012
3	Topoisomerase II InhibitorsIBA 01/2018 - 03/2012
3	Complement System Proteins (Complement)IBA 06/2016 - 05/2015
3	Metformin (Glucophage)FDA LinkGeneric 12/2013 - 02/2013
2	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2022 - 01/2020
2	Therapeutic UsesIBA 01/2021 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 03/2011
2	A-Form DNA (A-DNA)IBA 01/2018 - 12/2013
2	ResveratrolIBA 12/2015 - 12/2013
2	Tamoxifen FDA LinkGeneric 01/2015 - 03/2014
2	MutS ProteinsIBA 01/2015 - 04/2014
2	Hormones (Hormone)IBA 01/2015 - 03/2014
2	ElementsIBA 01/2015 - 04/2014
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2014 - 12/2012
2	pyrimidineIBA 03/2014 - 07/2011
2	PlatinumIBA 02/2013 - 07/2011
2	Platinum Compounds (Compounds, Platinum)IBA 07/2011 - 08/2010
2	Mitogen-Activated Protein Kinase 3IBA 07/2011 - 06/2003
2	Benzo(a)pyreneIBA 08/2008 - 05/2008
1	Monoclonal AntibodiesIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	ThymidineIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2020
1	Capsaicin (Zostrix)FDA Link 05/2019
1	IonophoresIBA 01/2019
1	Potassium IonophoresIBA 12/2016
1	Phosphotransferases (Kinase)IBA 04/2016
1	X-ray Repair Cross Complementing Protein 1IBA 12/2015
1	Minocycline (Cyclops)FDA LinkGeneric 10/2015
1	Tetracycline (Achromycin)FDA LinkGeneric 10/2015
1	Estrogens (Estrogen)FDA Link 01/2015
1	LipopeptidesIBA 01/2015
1	Estrogen ReceptorsIBA 03/2014
1	triphenylethyleneIBA 03/2014
1	QuinazolinesIBA 12/2013
1	EndonucleasesIBA 12/2013
1	StilbenesIBA 07/2013
1	AntioxidantsIBA 07/2013
1	arachidin-1IBA 07/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2013
1	Antineoplastic Agents (Antineoplastics)IBA 02/2013
1	ProdigiosinIBA 07/2012
1	Cytotoxins (Cytolysins)IBA 07/2011
1	U 0126 (UO 126)IBA 07/2011
1	ProdrugsIBA 03/2011
1	Capecitabine (Xeloda)FDA Link 03/2011
1	Gemcitabine FDA Link 12/2010
1	DeoxycytidineIBA 12/2010
1	Carboplatin (JM8)FDA LinkGeneric 08/2010
1	AnthraquinonesIBA 08/2010
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2010
1	Free RadicalsIBA 04/2010
1	Hydroxyl RadicalIBA 04/2010
1	titanium dioxide (Titania)FDA Link 12/2009
1	Recombinases (Recombinase)IBA 09/2009
1	Celecoxib (Celebrex)FDA Link 09/2009
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2009
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2009
1	Protein Kinases (Protein Kinase)IBA 08/2008

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2020 - 03/2011
4	Therapeutics 01/2021 - 09/2009